Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples